Previous Article | Next Article ![]()
Infection and Immunity, October 2001, p. 6110-6118, Vol. 69, No. 10
Oral Biology and Pathology, School of Dentistry, University
of Queensland, Brisbane, Queensland 4072,1
Discipline of Immunology and Microbiology, University of
Newcastle, Newcastle, New South Wales 2300,2
and Department of Pathology, Queen Elizabeth II
Medical Centre, University of Western Australia, Nedlands, Western
Australia 6907,3 Australia
Received 25 January 2001/Returned for modification 21 March
2001/Accepted 23 July 2001
The purpose of this study was to identify the cell populations
involved in recovery from oral infections with Candida
albicans. Monoclonal antibodies specific for CD4+
cells, CD8+ cells, and polymorphonuclear leukocytes were
used to deplete BALB/c and CBA/CaH mice of the relevant cell
populations in systemic circulation. Monocytes were inactivated with
the cytotoxic chemical carrageenan. Mice were infected with
108 C. albicans yeast cells and monitored for
21 days. Systemic depletion of CD4+ and CD8+ T
lymphocytes alone did not increase the severity of oral infection compared to that of controls. Oral colonization persisted in animals treated with head and neck irradiation and depleted of CD4+
T cells, whereas infections in animals that received head and neck
irradiation alone or irradiation and anti-CD8 antibody cleared the
infection in a comparable fashion. The depletion of polymorphonuclear cells and the cytotoxic inactivation of mononuclear phagocytes significantly increased the severity of oral infection in both BALB/c
and CBA/CaH mice. High levels of interleukin 12 (IL-12) and gamma
interferon (IFN- Clinical and laboratory studies have
shown that neutrophils (polymorphonuclear leukocytes [PMNLs]) play a
major role in host defense against systemic candidiasis (2, 3,
27, 31), although recent work suggests that there is also a role
for T cells and their cytokines in recovery from this disease
(45). Oral candidiasis, however, has been consistently
associated with defects in the cell-mediated arm of the immune response
(30, 33, 38). For example, children with thymic aplasia
(DiGeorge syndrome) (11), patients suffering from human
immunodeficiency virus and AIDS (34, 49), and those
undergoing therapeutic chemotherapy and radiotherapy (42)
are all more susceptible to oral candidiasis.
The essential role for CD4+ T cells in oral infection has
been demonstrated in an immunodeficient nu/nu mouse model
(C. S. Farah et al., submitted for publication). However,
since T cells do not kill Candida spp. directly, phagocytic
cells clearly play an important role in mediating clearance of the
yeast from the oral cavity. Both neutrophils and macrophages have been
shown to exert candidacidal activity and probably represent the first line of defense against this yeast (16, 24). Indeed,
neutrophil infiltration is the hallmark of oral candidal lesions
(44, 51), often forming microabscesses in the epithelium
of infected tissue.
Many patients with defects in neutrophil and macrophage function are
susceptible to oral candidiasis. Patients suffering from primary
immunodeficiencies such as hereditary myeloperoxidase deficiency have
defects in neutrophil and macrophage activity due to an absence of
myeloperoxidase from their granules, while patients with
Chediak-Higashi syndrome have abnormal PMNLs with neutropenia and
impaired chemotaxis (55). These defects are thought to
account for the impaired killing of Candida albicans in
these patients, making them more susceptible to oral candidiasis.
Although the number and function of neutrophils and monocytes in
T-cell-deficient nu/nu mice are normal (22),
these mice could not clear an oral infection unless they were
reconstituted with T lymphocytes (Farah et al., submitted). This
finding suggests that, although phagocytic cells are present in these
mice, their anticandidal activity is dependent on T-cell factors, most
likely cytokines.
Therefore, the purposes of this study were to evaluate the relative
contributions of CD4+ and CD8+ T lymphocytes in
an inbred mouse model by monoclonal depletion and radiation treatment
and to explore the contribution of neutrophils and macrophages to local
defense against C. albicans.
Mice.
Specific-pathogen-free BALB/c and CBA/CaH female mice,
6 to 8 weeks of age, were purchased from the Animal Resources Centre, Perth, Australia. These mice undergo routine microbiological screening and do not harbor C. albicans in the gut. Animal experiments
were approved by the Animal Experimentation Ethics Committee of the University of Queensland and carried out in accordance with the National Health and Medical Research Council's Australian Code of
Practice for the Care and Use of Animals for Scientific Purposes, 1997. Mice were housed in standard cages and provided with food and water ad libitum.
Yeast.
C. albicans isolate 3630 was obtained from
a patient with cutaneous candidiasis, submitted to the Mycology
Reference Laboratory at the Royal North Shore Hospital, Sydney,
Australia, and stored at Oral infection.
Mice were inoculated orally with
108 live C. albicans yeast cells in 20 µl of
PBS. The infection was monitored by swabbing the oral cavity with
sterile cotton swabs moistened with sterile PBS and plating the yeast
on Sabouraud's agar plates. Agar plates were incubated for 48 h
at 37°C. All inoculation and sampling procedures were carried out
with the mice being under halothane anaesthesia. CFU were counted on
Sabouraud's agar plates. The counts were assigned into five groups
correlating with the level of recoverable yeast from the oral cavity.
This process provided a semiquantitative measure of the level of
floridity of the infection. The scoring system used was as follows: 0, no detectable yeast; 1, 1 to 10 CFU/plate; 2, 11 to 100 CFU/plate; 3, 101 to 1,000 CFU/plate; and 4, 1,000 or more CFU/plate.
Histopathology.
Mice were sacrificed at various time points
throughout the course of the experiment for histopathological
examination of tissues. Skulls were fixed in 10% neutral buffered
formalin (pH 7.0) and decalcified in a 5% formic acid and sodium
formate mixture. Frontal sections of the skulls were taken at
approximately 3-mm intervals, with consecutive sections being stained
with hematoxylin and eosin and according to the periodic acid-Schiff
technique. Sections were examined by light microscopy.
CD4+- and CD8+-T-cell depletion.
The
hybridoma cell lines YTS191.1.2 and YTS169.4.2.1 that produce
monoclonal antibodies specific for mouse CD4+ and
CD8+ T lymphocytes, respectively (12, 41),
were obtained courtesy of S. Cobbold, Sir William Dunn School of
Pathology, University of Oxford, Oxford, United Kingdom. Cell lines
were seeded into a miniPERM Bioreactor (Heraeus, Osterode/Harz,
Germany) at 6 × 104 cells/ml in RPMI 1640 tissue
culture medium (Trace Biosciences, Castle Hill, New South Wales,
Australia). Antibodies were produced by the Antibody Facility at the
Centre for Molecular and Cellular Biology, University of Queensland.
The concentration of protein was calculated, and the supernatant was
pretested in mice to determine the optimal dose for depletion. Mice
were depleted of lymphocytes by intraperitoneal injection of 300 µg
of antibody on day Neutrophil depletion.
A cell line (RB6-8C5) that secretes a
monoclonal antibody specific for mouse neutrophils was obtained
courtesy of R. Coffman, DNAX Institute, Palo Alto, Calif. This rat
immunoglobulin G2b (IgG2b) monoclonal antibody reacts with the Gr-1
surface antigen expressed on murine granulocytes but not with monocytes
or lymphocytes (22, 43). The cell line was grown as
described above. The supernatant was used without further purification
and pretested to determine the optimal dose for depletion. Mice were
depleted of neutrophils by intraperitoneal administration of 300 µg
of the antibody preparation on day Macrophage inactivation.
Carrageenan (type IV Intramucosal injection of depleting antibodies.
Mice were
injected with depleting antibody for CD4 or CD8 directly into the oral
tissues. A dose of 50 µl was injected intramucosally into the left
and right buccal mucosae according to the time scale noted above. The
mice were infected with Candida yeast and monitored for 21 days. Control animals received an injection of an equal volume of PBS.
Radiation.
Mice received head and neck irradiation
equivalent to 800 rads using a Cobalt-60 Cell surface antigen staining.
Lymphocytes were obtained by
pressing either spleens or lymph nodes through a sterile metal sieve,
followed by filtration through an 80-µm- pore-size nylon mesh. The
cells were resuspended in 6 ml of PBS and separated on a Ficoll
gradient by placing the cell suspension over 4 ml of Ficoll-Hypaque
(Pharmacia Biotech, Uppsala, Sweden). The gradient was centrifuged at
700 × g for 25 to 30 min at room temperature. The buffy
coat interface was carefully removed, washed twice in PBS, and
resuspended in 1 ml of PBS. Viable lymphocytes were counted in a
hemocytometer after being stained with trypan blue and adjusted to the
appropriate concentration for injection into recipient mice. Cells
(106) were stained in 50 µl of 0.1% PBS-NaN3
for 30 min at 4°C in the dark, using an appropriate concentration of
a fluorochrome-conjugated monoclonal antibody specific for a cell
surface antigen or isotype control (1 µl of FITC-rat anti-mouse CD4
[IgG2a], 1.5 µl of R-PE-rat anti-mouse CD8 [IgG2a], 1 µl of FITC-rat IgG2a isotype control Ig, and 1.5 µl of
R-PE-rat IgG2a isotype control Ig; PharMingen, San Diego,
Calif.). The cells were washed twice in 0.1% PBS-NaN3, spun at 1,500 rpm for 5 min, and resuspended in 500 µl of 1%
Formalin. Cells were analysed by fluorescence-activated cell sorting.
Cytokine ELISA.
Lymphocytes isolated from the submandibular
and superficial cervical (SMSC) lymph nodes were cultured ex vivo for 3 days at 4 × 106 cells/ml in RPMI 1640 tissue culture
medium, without antigen stimulation. The supernatant was collected,
filtered through a 0.8-µm-pore-size filter, and stored at
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.10.6110-6118.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
T Cells Augment Monocyte and Neutrophil Function
in Host Resistance against Oropharyngeal Candidiasis
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
) were produced by lymphocytes from the draining
lymph nodes of recovering animals, whereas IL-6, tumor necrosis factor
alpha, and IFN-
were detected in the oral mucosae of both
naïve and infected mice. The results indicate that recovery
from oropharyngeal candidiasis in this model is dependent on
CD4+-T-cell augmentation of monocyte and neutrophil
functions exerted by Th1-type cytokines such as IL-12 and
IFN-
.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
70°C in Sabouraud's broth-15% (vol/vol)
glycerol. For use, yeast cells were grown in Sabouraud's broth for
48 h at room temperature with continuous agitation on a magnetic
stirrer. Blastospores were washed in phosphate-buffered saline (PBS)
and adjusted to the appropriate concentration for inoculation.
2 and then every second day throughout the course
of the experiment. Control mice were injected with PBS. Depletion was
confirmed by fluorescence-activated cell sorting analysis of spleen and
lymph node cells on days 1 and 4 following antibody injection and at the termination of the experiment using fluorescein isothiocyanate (FITC) conjugated and R-phycoerythrin
(R-PE)-conjugated commercial antibodies specific for mouse
CD4 and CD8, respectively.
2 and then at 48-h intervals until
day 8. Control mice received a similar course of PBS injections. Complete depletion of PMNLs was confirmed by blood smears taken 1 and 4 days after treatment with the monoclonal antibody and stained with
May-Grunwald-Giemsa stain. Granulocyte and monocyte numbers were
monitored throughout the course of the experiment with the use of
stained blood smears.
;
Sigma-Aldrich, St. Louis, Mo.) was dissolved in sterile PBS at 5 mg/ml.
The solution was heated to 56°C to ensure complete solubilization.
Mice were treated by intraperitoneal injection of 200 µl (1 mg) of
carrageenan 2 days prior to oral inoculation. Control mice received 200 µl of sterile PBS.
-radiation source. The mice
were anesthetized and placed one at a time in a protective lead
chamber, with only the head in the direct path of radiation. Mice were
inoculated with the yeast immediately after irradiation as described above.
20°C
until analyzed. The culture supernatant was assayed for interleukin 4 (IL-4), IL-10, IL-12, and gamma interferon (IFN-
) by enzyme-linked
immunosorbent assay (ELISA) using matched-antibody pairs and
recombinant cytokines as standards. Briefly, immuno-polysorb microtiter
plates (Nunc, Roskilde, Denmark) were coated with capture rat
monoclonal anti-IL-4 (IgG1), IL-10 (IgG1), IL-12 (IgG2a), or IFN-
(IgG1) antibody (PharMingen) at 1 µg/ml in sodium bicarbonate buffer
overnight at 4°C. The wells were washed and then blocked with 1%
bovine serum albumin-PBS before the culture supernatants and the
appropriate standard were added to each well. Biotinylated rat
monoclonal anti-IL-4, IL-10, IL-12, or IFN-
antibody (PharMingen) at
2 µg/ml was added as the second antibody. Detection was carried out
with streptavidin peroxidase and tetramethylbenzidine. The results were
expressed as net Candida-induced counts from which the
background was subtracted (Table 1).
TABLE 1.
Cytokine production by BALB/c mouse SMSC lymph node cells
after oral infection with 108 C. albicans yeast
cellsa
RNA isolation.
Tissues were homogenized in 1 ml of Ultraspec
RNA reagent (Biotecx Laboratories, Houston, Tex.) per 10 to 100 mg of
tissue using an Ultra-Turrax T25 homogenizer. The homogenate was held for 5 min at 4°C to permit the complete dissociation of nucleoprotein complexes, at which time 200 µl of chloroform was added and the tubes
were vigorously shaken for 15 and then stored on ice for another 5 min.
The homogenate was centrifuged at 10,000 × g for 15 min at
4°C, and the upper phase was transferred to a new Eppendorf tube
without the interphase being disturbed. An equal volume of isopropanol
was added, and samples were stored on ice for 10 min and then
centrifuged at 10,000 × g for another 10 min at 4°C. The RNA pellet was washed twice in 1 ml of 75% ethanol by vortexing and subsequent centrifugation at 10,000 × g for 5 min
at 4°C. The pellet was briefly dried for 5 to 10 min and dissolved in 25 µl of diethyl pyrocarbonate-water by vortexing for 1 min. The concentration and purity of the RNA samples were determined by spectrophotometry at 260 and 280 nm and then the samples were stored at
70°C until required.
RT-PCR.
cDNA was prepared by reverse transcription (RT) of 1 µg of each RNA, using an oligo(dT)15 primer and avian
myeloblastosis virus reverse transcriptase (Promega, Madison, Wis.).
Briefly, 4 µl of 25 mM MgCl2 solution, 2 µl of 10× PCR
amplification buffer (670 mM Tris-HCl, 166 mM
[NH4]2SO4, 4.5% Triton X-100, 2 mg of gelatin/ml [BioTech International, Western Australia,
Australia]), 2 µl of a 10 mM concentration of a
deoxynucleoside triphosphate mix, 0.5 µl of RNasin, 0.75 µl
(15 U) of avian myeloblastosis virus reverse transcriptase, 0.5 µg of
oligo(dT)15 primer, and 1 µg of an mRNA sample were
incubated in a 20-µl reaction mix at 42°C for 1 h, heated to
99°C for 5 min, and then cooled on ice. cDNA was amplified by PCR in
an amplification mix consisting of 2 µl of 25 mM MgCl2,
2.5 µl of 10× reaction buffer, 2 µl of 25 a mM concentration
of the deoxynucleoside triphosphate mix, 0.5 U of Taq DNA
polymerase, the appropriate primer, and 1 µl of cDNA in a total
volume of 25 µl. Negative controls (without cDNA) were included for
all primers used in each run. The mixture was amplified using a PTC-100
programmable thermal cycler (MJ Research, Inc., Watertown, Mass.). The
amplification protocol was 35 to 40 cycles of 94°C for 30 s,
60°C for 30 s, and 72°C for 1 min. Following amplification, 10 µl of product was analyzed by electrophoresis through 2.5% (wt/vol)
agarose gels. The gels were stained with ethidium bromide, and the
bands were visualized using a UV transilluminator (GelDoc 2000;
Bio-Rad, Regents Park, New South Wales, Australia) with appropriate
software (MultiAnalyst version 1.1; Bio-Rad, Hercules, Calif.). Primer
sequences for IL-2, IL-4, IL-6, IFN-
, and tumor necrosis factor
alpha (TNF-
) were obtained from published data (36) and
synthesized at the Australian Neuromuscular Research Institute, Perth,
Western Australia, Australia. The sequence for IL-10 was taken from
published data (47) and synthesized by Bresatec, Adelaide,
South Australia, Australia.
Statistics. Quantitative data were analyzed using the statistical features of GraphPad Prism version 2.01 (GraphPad, Inc., San Diego, Calif.). Student's t test and one-way analysis of variance (ANOVA) were used with a P of <0.05 unless otherwise specified.
| |
RESULTS |
|---|
|
|
|---|
CD4+- and CD8+-T-cell depletion.
BALB/c and CBA/CaH mice were depleted of either CD4+ or
CD8+ or both CD4+ and CD8+ T cells
by systemic administration of specific depleting monoclonal antibodies. Initially, the antibodies achieved approximately 90% depletion, which dropped to 50 to 60% by day 8. Animals were infected with 108 C. albicans yeast cells 2 days
following the first antibody injection. Oral colonization in mice
treated with depleting antibody was not significantly different from
that of control animals, for both BALB/c and CBA/CaH mice (Fig.
1). Although spleen and lymph node T-cell
populations were depleted, no effect was seen at the mucosal surface
with regard to the clearance or colonization of the yeast in the oral
cavity.
|
Intramucosal injection of CD4- and CD8-depleting antibodies. Depleting antibodies were injected intramucosally into BALB/c and CBA/CaH mice. Control animals were injected with PBS to control for the effect of trauma. Both test and control groups were subsequently inoculated 2 days later with C. albicans. Treatment with CD4- and CD8-specific antibodies had no effect on the severity of oral colonization; however, the anti-CD4 antibody did prolong the infection compared to that of control mice (data not shown).
Radiation and depletion of CD4+ and CD8+ T
cells.
Failure to achieve an effect at the mucosal surface by
systemic and intramucosal injections of anti-CD4 and anti-CD8
antibodies suggested that T cells resident in the oral mucosa were
contributing to host defense in these animals. In order to eliminate
the contribution of these resident T cells to responses in the oral
mucosa, BALB/c mice were treated with irradiation to the head and neck
and depleted systemically of either CD4+ or
CD8+ T cells. Control mice received an equivalent dose of
irradiation with no antibody treatment. All animals were infected with
108 C. albicans yeast cells and monitored.
Radiation treatment significantly exacerbated the severity of the oral
infection with the yeast, as demonstrated by the high scores seen on
days 8 and 14 following infection. Mice that were treated with
irradiation alone were able to significantly eliminate the yeast by day
21, as were those that were irradiated and depleted of CD8+
T cells (Fig. 2). Mice that received
antibody specific for CD4+ T cells did not clear the
infection on day 21. This was significant (P < 0.01)
compared to the responses of control mice that received irradiation
alone and those that received head and neck irradiation in conjunction
with anti-CD8 antibody (P < 0.001). There was no difference in the severity of the disease between control mice and
nonirradiated animals that were only systemically depleted at any time
point following infection (data not shown).
|
Cytokine production by lymph node cells using ELISA.
ELISA
performed on culture supernatants of SMSC lymphocytes isolated from
BALB/c mice following oral infection demonstrated high levels of IL-12
on days 8 (293 pg/ml) and 21 (451 pg/ml), with moderate titers on day 4 (95 pg/ml) and low levels on day 14 (46 pg/ml). Concentrations of
IFN-
were moderate (35 to 206 pg/ml) and appeared to follow the
pattern of production of IL-12. Low levels of IL-10 (44 to 66 pg/ml)
were detected during the course of the infection, whereas IL-4 was
detected only on day 14 (39 pg/ml). The concentrations of IL-12 and
IFN-
were significantly higher than those of IL-4 and IL-10 on days
8 and 21 but not so on days 4 and 14 (Table 1).
Cytokine gene expression in oral tissues using RT-PCR.
Oral
mucosae and tongues from BALB/c and CBA/CaH mice were examined for the
presence of RNA for IL-2, IL-4, IL-6, IL-10, TNF-
, and IFN-
.
Message for IL-2, IL-4, and IL-10 was undetectable in both
naïve and infected BALB/c mice. IL-6, TNF-
, and IFN-
were
detected in both naïve and infected oral tissue. The cytokine profile for CBA/CaH mice was identical to that seen in BALB/c oral tissues.
Neutrophil depletion and macrophage inactivation.
The effects
of depletion of polymorphonuclear phagocytes and the inactivation of
monocytes/macrophages on the severity and duration of oral colonization
were determined in BALB/c and CBA/CaH mice. In BALB/c mice, PMNL
depletion alone increased the severity of the infection compared to
that of control mice (Fig. 3A). Results were significant (P < 0.05) only on days 1, 4, and 6. Macrophage inactivation alone significantly increased the severity of
the infection (P < 0.01) compared to that of controls
on days 1, 2, 4, 6, and 8 (Fig. 4A).
Eliminating both phagocytic cell types significantly increased the
severity of the infection (P < 0.01), but this
increase was only slightly greater than that seen after macrophage
elimination alone (Fig. 5A). PMNL depletion alone did not affect the
severity of the infection in CBA/CaH mice, nor did macrophage
inactivation, except on day 1 (Fig. 3B and 4B). Ablation of both
neutrophils and macrophages was required to significantly increase the
severity of the infection in CBA/CaH mice (P < 0.01) (Fig. 5B). The increase in severity of
the oral infection when both phagocytic cell types were inactivated was
more dramatic in CBA/CaH than in BALB/c mice (Fig. 5).
|
|
|
Histopathology of oral tissues following PMNL depletion and
macrophage inactivation.
Histopathological examination of oral
tissues following neutrophil depletion and macrophage inactivation
revealed more abundant Candida hyphae penetrating the
keratinized surface epithelium (Fig. 6).
CBA/CaH mice (Fig. 6B) were more heavily colonized than BALB/c mice
(Fig. 6A). There was evidence of high connective tissue papillae and
thickening and blunting of rete ridges. Polymorphonuclear microabscesses were not present, but transmigrating intraepithelial PMNLs were still observed.
|
| |
DISCUSSION |
|---|
|
|
|---|
T lymphocytes have been implicated in recovery from systemic (45), gastrointestinal (4, 5, 8, 9), and oral (10, 17) infections with C. albicans. In systemic infection, Th1 cytokines correlate with resistance and Th2 cytokines correlate with chronic disease (45), but less is known about the relative importance and function of the T-cell subsets in oral infection.
In this study, depletion of CD4+ and CD8+ T cells significantly decreased the numbers of these cells in the systemic circulation but failed to demonstrate any role for these cell populations in clearance of the yeast from the mucosal surface. Animals treated with the depleting antibodies were no more susceptible to oral challenge than control mice and cleared the infection in a similar fashion. Comparable results have been observed in experimental vaginal candidiasis (18, 19). Systemic administration of anti-CD4 and anti-CD8 antibodies in these studies effectively depleted the cells in systemic circulation but had no effect on the vaginal C. albicans burden in mice after a primary or secondary vaginal inoculation (19). It was suggested that antibodies administered systemically were either unable to reach the mucosa or did not reach the mucosa at high-enough concentrations to achieve a detectable effect (18). However, Fidel et al. were able to demonstrate that intravaginal injection of depleting antibodies resulted in T-cell depletion in both the vagina and the systemic circulation (18). In the present study, subset-specific monoclonal antibodies were injected into the oral mucosae of BALB/c mice prior to C. albicans inoculation. No significant effect on oral colonization was observed in animals depleted of CD4+ or CD8+ T cells, although the duration of infection was slightly prolonged in mice depleted of CD4+ cells.
It is possible that the antibodies used in our experiments were not
effective against all T cells present in the oral mucosa, since mucosal
T cells are phenotypically and functionally different than those in the
periphery (50). Flow cytometric analysis of T cells in
oral mucosal epithelium shows that while
/
T cells often
predominate, the percentages of
/
T cells are always considerably higher than in the periphery (25, 32, 39). Moreover,
mucosal
/
T cells are not identical to their systemic
counterparts (50). Both
/
and
/
T cells may be
resident in the oral mucosa, and both may have a role in the clearance
of the yeast from the mucosal surfaces (10, 17). In a
recent study, mice made deficient for
/
or
/
T cells
(
-or
-chain T-cell receptor knockout mice, respectively) were
more susceptible to orogastric candidiasis than immunocompetent
controls (29). Nevertheless, irradiated mice depleted of
CD4+ cells showed an impaired ability to clear the
infection compared to that of mice that were irradiated and depleted of
CD8+ cells or irradiated controls. This result demonstrated
that the circulating CD4+ T cells in mice were able to
repopulate the oral mucosa or draining lymph nodes and exert a
protective effect against the yeast.
In the present experiments, depletion of CD8+ cells resulted in a slightly accelerated clearance of yeast from the oral cavity, but it remains to be established whether this was due to deleterious activity of the CD8+ cells themselves or to some regulatory interaction with the CD4+ cells. The precise role of CD8+ lymphocytes in host defense against candidiasis has not yet been defined. Activated CD8+ cells have been shown to have the potential to lyse Candida-infected macrophages (48), to reduce tissue damage associated with systemic infection (1), and to have some protective effect against systemic infection, although this potential was masked by the immunopathological activities of CD4+ T cells (13).
In an investigation of the role for IL-2 and IFN-
in mucosal
candidiasis, Cantorna and Balish (5) failed to demonstrate a substantial role for these cytokines in protecting the oral mucosa
from candidal infection, although CD4+ T lymphocytes were
crucial in preventing candidiasis in this model. Cenci et al.
(9) have previously concluded that activation of Th1- but
not Th2-like responses may be responsible locally for controlling
gastrointestinal candidiasis and generating protective immunity
(9). They have also shown that mice deficient for the
IFN-
receptor fail to mount protective Th1-mediated acquired immunity upon mucosal challenge (8). The impaired
Th1-mediated resistance correlated with defective IL-12 responsiveness
but not IL-12 production. Cenci et al. concluded that IFN-
was
required for development of IL-12-dependent protective Th1-dependent immunity.
IL-12 is produced by phagocytic cells and is known to act on T
lymphocytes by inducing proliferation and production of cytokines such
as IFN-
(52-54). In turn, IFN-
activates
macrophages and enhances their phagocytic abilities (35,
37). IL-12 has been demonstrated to play a role in, and is an
obligatory factor for, Th1 induction. It acts directly on Th1
lymphocytes, and part of this activity is due to the induction of
IFN-
production by T and NK cells. IL-12 and IFN-
are known to be
involved in natural and acquired aspects of the immune response
(52), and it is perhaps some aspect of this interaction
that underlies the effector function of CD4+ T cells in the
host response to oral candidiasis.
From the data presented in this study and those of others (5, 8,
9), there is little evidence that IL-2, IL-4, or IL-10 plays a
significant role in mucosal candidiasis. The production of Th1-type
cytokines such as IL-12, IFN-
, and TNF-
appears to be relevant to
the clearance of this yeast from the oral mucosal tissues of infected mice.
The role of innate defense mechanisms against oral candidiasis were examined in BALB/c and CBA/CaH mice by monoclonal antibody depletion of neutrophils and cytotoxic inactivation of macrophages.
It is well established, by both clinical and experimental studies, that either quantitative (3, 27) or qualitative (2, 31) neutrophil defects are a predisposing factor to disseminated candidiasis and that depletion of neutrophils significantly increases the susceptibility to systemic candidiasis (20, 46). Neutrophils provide the first line of defense against systemic candidiasis, but their role in oral candidiasis has not been fully explored. The RB6-8C5 monoclonal antibody is a rat IgG2b reagent that selectively binds to and depletes mature mouse neutrophils and eosinophils but not lymphocytes and macrophages (14, 43). In the present study, depletion of neutrophils in BALB/c, but not in CBA/CaH, mice significantly increased the severity of oral infection.
The other cell type with major anticandidal activity is the macrophage. Macrophages are able to kill C. albicans through several effector pathways, and their candidacidal state can be enhanced by activation with a number of different cytokines. Several techniques have been used to eliminate macrophages, including liposomes containing dichloromethylene diphosphonate, silica, and carrageenan. In our experiments the use of carrageenan was a simple and effective method to eliminate macrophages in order to study their contribution to host resistance against oral candidiasis.
Elimination of macrophages increases susceptibility to systemic candidiasis (23, 27, 40), but few studies have assessed the role of monocytic phagocytes in resistance to mucosal candidiasis. Impairment of macrophage function with poly(I-C) increased the susceptibility of scid mice to disseminated candidiasis of endogenous origin (gastrointestinal tract) (26, 28), but immunocompetent controls were resistant to mucosal candidiasis after poly(I-C) treatment. In fact, interference with both macrophage and neutrophil function was necessary to render these mice susceptible to mucosal infection (28). In the present experiment, concurrent depletion of neutrophils and elimination of macrophages also induced a substantial increase in susceptibility in BALB/c and CBA/CaH mice. Although each treatment alone significantly increased the susceptibility of BALB/c mice, both were required to demonstrate an effect in the CBA/CaH strain. This finding suggests that in CBA/CaH mice either neutrophils or macrophages are capable of maintaining an effective host response but that in BALB/c mice there may be limitations in the production or function of these cells that render them more susceptible to the effects of depletion.
Neutrophils in infected oral tissue are the hallmark of C. albicans infection, and activation of macrophages appears to be necessary for the full expression of resistance to disease. It was expected that depletion of either of these cells would lead to a more pronounced exacerbation of the infection at the mucosal surface. It is possible that each of these phagocytic subsets can compensate for the absence of the other, thereby containing the initial spread and allowing the T cells to exert their functions. Additionally, it must be noted that a significant effect of carrageenan administration is granulocytosis (23). It has been reported that the number of PMNLs in peripheral blood increased after carrageenan administration, possibly explaining the increased resistance of treated mice to systemic candidiasis (23).
It is evident that neutrophils are important effector cells against C. albicans (15) and that, together with macrophages, they are probably responsible for the ultimate elimination of the fungus. However, recent studies of humans (6, 7) and mice (46) suggest that neutrophils are also capable of synthesizing immunomodulatory cytokines such as IL-10 and IL-12. These cytokines are secreted by neutrophils early in infection and are therefore important in the generation of the anticandidal Th-cell response, which in turn modulates the functions of neutrophils. In our work, it is possible that IL-12 production by neutrophils selected a Th1-type response by T cells.
In conclusion, this article emphasizes the importance of
CD4+ T lymphocytes in oral candidiasis and supports
clinical observations that link oral C. albicans infections
to defects in cell-mediated immunity. The data also support the role
for Th1-type cytokines and protective immunity in the resolution of
oral candidiasis in infected mice. It appears that the clearance of an
oral C. albicans infection is dependent on
CD4+-T-cell augmentation of monocyte and neutrophil
functions exerted by Th1-type cytokines such as IL-12 and IFN-
.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by the National Health and Medical Research Council of Australia. C.S.F. was supported by an NH and MRC dental postgraduate research scholarship.
We thank Slavica Pervan for the preparation of the histological samples and Karen Drysdale for the RT-PCR assays.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Oral Biology and Pathology, The University of Queensland, Brisbane, QLD 4072, Australia. Phone: 61 7 3365 8840. Fax: 61 7 3365 1109. E-mail: c.farah{at}uq.edu.au.
Editor: T. R. Kozel
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Ashman, R. B., A. Fulurija, and J. M. Papadimitriou. 1999. Both CD4+ and CD8+ lymphocytes reduce the severity of tissue lesions in murine systemic candidiasis, and CD4+ cells also demonstrate strain-specific immunopathological effects. Microbiology 145:1631-1640[Abstract]. |
| 2. |
Ashman, R. B., and J. M. Papadimitriou.
1991.
Susceptibility of beige mutant mice to candidiasis may be linked to a defect in granulocyte production by bone marrow stem cells.
Infect. Immun.
59:2140-2146 |
| 3. | Bodey, G. P., M. Buckley, Y. S. Sathe, and E. J. Freireich. 1966. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann. Intern. Med. 64:328-340. |
| 4. |
Cantorna, M. T., and E. Balish.
1990.
Mucosal and systemic candidiasis in congenitally immunodeficient mice.
Infect. Immun.
58:1093-1100 |
| 5. |
Cantorna, M. T., and E. Balish.
1991.
Role of CD4+ lymphocytes in resistance to mucosal candidiasis.
Infect. Immun.
59:2447-2455 |
| 6. | Cassatella, M. A. 1995. The production of cytokines by polymorphonuclear neutrophils. Immunol. Today 16:21-26[CrossRef][Medline]. |
| 7. | Cassatella, M. A., L. Meda, S. Gasperini, A. D'Andrea, X. Ma, and G. Trinchieri. 1995. Interleukin-12 production by human polymorphonuclear leukocytes. Eur. J. Immunol. 25:1-5[Medline]. |
| 8. |
Cenci, E.,
A. Mencacci,
G. Delsero,
C. F. Dostiani,
P. Mosci,
A. Bacci,
C. Montagnoli,
M. Kopf, and L. Romani.
1998.
IFN-gamma is required for IL-12 responsiveness in mice with Candida albicans infection.
J. Immunol.
161:3543-3550 |
| 9. | Cenci, E., A. Mencacci, R. Spaccapelo, L. Tonnetti, P. Mosci, K. H. Enssle, P. Puccetti, L. Romani, and F. Bistoni. 1995. T helper cell type-1 (Th1)- and Th2-like responses are present in mice with gastric candidiasis but protective immunity is associated with Th1 development. J. Infect. Dis. 171:1279-1288[Medline]. |
| 10. | Chakir, J., L. Cote, C. Coulombe, and N. Deslauriers. 1994. Differential pattern of infection and immune response during experimental oral candidiasis in BALB/c and DBA/2 (H-2d) mice. Oral Microbiol. Immunol. 9:88-94[Medline]. |
| 11. | Cleveland, W. W., B. J. Fogel, W. T. Brown, and H. E. M. Kay. 1968. Fetal thymic transplant in a case of DiGeorge syndrome. Lancet ii:1211-1214. |
| 12. | Cobbold, S. P., A. Jayasuriya, A. Nash, T. D. Prospero, and H. Waldmann. 1984. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature 312:548-551[CrossRef][Medline]. |
| 13. | Coker, L. A., C. M. Mercadal, B. T. Rouse, and R. N. Moore. 1992. Differential effects of CD4+ and CD8+ cells in acute, systemic murine candidosis. J. Leukoc. Biol. 51:305-306[Abstract]. |
| 14. |
Conlan, J. W., and R. J. North.
1994.
Neutrophils are essential for early anti-Listeria defense in the liver, but not in the spleen or peritoneal cavity, as revealed by a granulocyte-depleting monoclonal antibody.
J. Exp. Med.
179:259-268 |
| 15. | Diamond, R. D., R. A. Clark, and C. C. Haudenschild. 1980. Damage to Candida albicans hyphae and pseudohyphae by the myeloperoxidase system and oxidative products of neutrophil metabolism in vitro. J. Clin. Investig. 66:908-917. |
| 16. | Diamond, R. D., and C. C. Haudenschild. 1981. Monocyte-mediated serum-independent damage to hyphal and pseudohyphal forms of Candida albicans in vitro J. Clin. Investig. 67:173-182. |
| 17. |
Elahi, S.,
G. Pang,
R. Clancy, and R. B. Ashman.
2000.
Cellular and cytokine correlates of mucosal protection in murine model of oral candidiasis.
Infect. Immun.
68:5771-5777 |
| 18. | Fidel, P. L., Jr., W. Luo, J. Chabain, N. A. Wolf, and E. Van Buren. 1997. Use of cellular depletion analysis to examine circulation of immune effector function between the vagina and the periphery. Infect. Immun. 65:3939-3943[Abstract]. |
| 19. | Fidel, P. L., Jr., M. E. Lynch, and J. D. Sobel. 1995. Circulating CD4 and CD8 T cells have little impact on host defense against experimental vaginal candidiasis. Infect. Immun. 63:2403-2408[Abstract]. |
| 20. | Fulurija, A., R. B. Ashman, and J. M. Papadimitriou. 1996. Neutrophil depletion increases susceptibility to systemic and vaginal candidiasis in mice, and reveals differences between brain and kidney in mechanisms of host resistance. Microbiology 142:3487-3496[Abstract]. |
| 21. | Hestdal, K., F. W. Ruscetti, J. N. Ihle, S. E. Jacobsen, C. M. Dubois, W. C. Kopp, D. L. Longo, and J. R. Keller. 1991. Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells. J. Immunol. 147:22-28[Abstract]. |
| 22. | Holub, M. 1989. Immunology of nude mice. CRC Press, Inc., Boca Raton, Fla. |
| 23. | Hurtrel, B., and P. H. Lagrange. 1981. Comparative effects of carrageenan on systemic candidiasis and listeriosis in mice. Clin. Exp. Immunol. 44:355-358[Medline]. |
| 24. | Hurtrel, B., P. H. Lagrange, and J. C. Michel. 1980. Systemic candidiasis in mice. IL- Main role of polymorphonuclear leukocytes in resistance to infection. Ann. Immunol. 131C:105-118. |
| 25. | Itohara, S., A. G. Farr, J. J. Lafaille, M. Bonneville, Y. Takagaki, W. Haas, and S. Tonegawa. 1990. Homing of a gamma delta thymocyte subset with homogeneous T-cell receptors to mucosal epithelia. Nature 343:754-757[CrossRef][Medline]. |
| 26. |
Jensen, J.,
A. Vazquez Torres, and E. Balish.
1992.
Poly(1 · C)-induced interferons enhance susceptibility of SCID mice to systemic candidiasis.
Infect. Immun.
60:4549-4557 |
| 27. | Jensen, J., T. Warner, and E. Balish. 1993. Resistance of SCID mice to Candida albicans administered intravenously or colonizing the gut: role of polymorphonuclear leukocytes and macrophages. J. Infect. Dis. 167:912-919[Medline]. |
| 28. | Jensen, J., T. Warner, and E. Balish. 1994. The role of phagocytic cells in resistance to disseminated candidiasis in granulocytopenic mice. J. Infect. Dis. 170:900-905[Medline]. |
| 29. |
Jones-Carson, J.,
A. Vazquez-Torres,
T. Warner, and E. Balish.
2000.
Disparate requirement for T cells in resistance to mucosal and acute systemic candidiasis.
Infect. Immun.
68:2363-2365 |
| 30. | Klein, R. S., C. A. Harris, C. B. Small, B. Moll, M. Lesser, and G. H. Friedland. 1984. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N. Engl. J. Med. 311:354-358[Abstract]. |
| 31. |
Lehrer, R. I.
1970.
Measurement of candidacidal activity of specific leukocyte types in mixed cell populations. I. Normal myeloperoxidase deficient and chronic granulomatous disease neutrophils.
Infect. Immun.
2:42 |
| 32. | Lundqvist, C., S. Baranov, S. Teglund, S. Hammarstrom, and M. L. Hammarstrom. 1994. Cytokine profile and ultrastructure of intraepithelial gamma-delta T cells in chronically inflammed human gingiva suggest a cytotoxic effector factor. J. Immunol. 153:2302-2312[Abstract]. |
| 33. | McCarthy, G. M. 1992. Host factors associated with HIV-related oral candidiasis. A review. Oral Surg. Oral Med. Oral Pathol. 73:181-186[CrossRef][Medline]. |
| 34. | McCarthy, G. M., I. D. Mackie, J. Koval, H. S. Sandhu, and T. D. Daley. 1991. Factors associated with increased frequency of HIV-related oral candidiasis. J. Oral Pathol. 20:332-336. |
| 35. | Morris, A. G. 1988. Interferons. Immunology 1(Suppl.):43-45[Medline]. |
| 36. | Murray, L. J., R. Lee, and C. Martens. 1990. In vivo cytokine gene expression in T cell subsets of the autoimmune MRL/Mp-lpr/lpr mouse. Eur. J. Immunol. 20:163-170[Medline]. |
| 37. | O'Garra, A. 1989. Peptide regulatory factors. Interleukins and the immune system 2. Lancet i:1003-1005[CrossRef]. |
| 38. | Pankhurst, C., and M. Peakman. 1989. Reduced CD4+ T cells and severe oral candidiasis in absence of HIV infection. Lancet i:672. |
| 39. |
Poussier, P., and M. Julius.
1994.
Intestinal intraepithelial lymphocytes: the plot thickens.
J. Exp. Med.
180:1185-1189 |
| 40. | Qian, Q., M. A. Jutila, N. Van Rooijen, and J. E. Cutler. 1994. Elimination of mouse splenic macrophages correlates with increased susceptibility to experimental disseminated candidiasis. J. Immunol. 152:5000-5008[Abstract]. |
| 41. |
Qin, S. X.,
S. Cobbold,
R. Benjamin, and H. Waldmann.
1989.
Induction of classical transplantation tolerance in the adult.
J. Exp. Med.
169:779-794 |
| 42. | Regezi, J. A., and J. J. Sciubba. 1999. White lesions, p. 83-121. In J. A. Regezi, and J.J. Sciubba (ed.), Oral pathology: clinical pathologic correlations, 3rd ed. W. B. Saunders Company, Philadelphia, Pa. |
| 43. |
Rogers, H., and E. Unanue.
1993.
Neutrophils are involved in acute, nonspecific resistance to Listeria monocytogenes in mice.
Infect. Immun.
61:5090-5096 |
| 44. | Rogers, T. J., and E. Balish. 1977. The role of activated macrophages in resistance to experimental renal candidiasis. J. Reticuloendothel. Soc. 22:309-318[Medline]. |
| 45. | Romani, L. 1999. Immunity to Candida albicans: Th1, Th2 cells and beyond. Curr. Opin. Microbiol. 2:363-367[CrossRef][Medline]. |
| 46. | Romani, L., A. Mencacci, E. Cenci, G. Delsero, F. Bistoni, and P. Puccetti. 1997. An immunoregulatory role for neutrophils in CD4+ T helper subset selection in mice with candidiasis. J. Immunol. 158:2356-2362[Abstract]. |
| 47. | Romani, L., A. Mencacci, L. Tonnetti, R. Spaccapelo, E. Cenci, S. Wolf, P. Puccetti, and F. Bistoni. 1994. Interleukin-12 but not interferon-gamma production correlates with induction of T helper type-1 phenotype in murine candidiasis. Eur. J. Immunol. 24:909-915[Medline]. |
| 48. | Romani, L., S. Mocci, E. Cenci, R. Rossi, P. Puccetti, and F. Bistoni. 1991. Candida albicans-specific Ly-2+ lymphocytes with cytolytic activity. Eur. J. Immunol. 21:1567-1570[Medline]. |
| 49. |
Scully, C.,
M. el Kabir, and L. P. Samaranayake.
1994.
Candida and oral candidosis: a review.
Crit. Rev. Oral Biol. Med.
5:125-157 |
| 50. | Sim, G.-K. 1995. Intraepithelial lymphocytes and the immune system. Adv. Immunol. 58:297-344[Medline]. |
| 51. |
Sohnle, P. G.,
M. M. Frank, and C. H. Kirkpatrick.
1976.
Mechanisms involved in elimination of organisms from experimental cutaneous Candida albicans infections in guinea pigs.
J. Immunol.
117:523-530 |
| 52. | Trinchieri, G. 1998. Interleukin-12: a cytokine at the interface of inflammation and immunity. Adv. Immunol. 70:83-243[Medline]. |
| 53. | Trinchieri, G., M. Kubin, G. Bellone, and M. A. Cassatella. 1993. Cytokine cross-talk between phagocytic cells and lymphocytes: relevance for differentiation/activation of phagocytic cells and regulation of adaptive immunity. J. Cell. Biochem. 53:301-308[CrossRef][Medline]. |
| 54. | Trinchieri, G., M. Wysocka, A. D'Andrea, M. Rengaraju, M. Aste-Amezaga, M. Kubin, N. M. Valiante, and J. Chehimi. 1992. Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammation. Prog. Growth Factor Res. 4:355-368[CrossRef][Medline]. |
| 55. | Wolff, S. M., D. C. Dale, R. A. Clark, R. K. Root, and H. R. Kimball. 1972. The Chediak-Higashi syndrome: studies of host defenses. Ann. Intern. Med. 76:293-306. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|